Balaxi Pharmaceuticals

quarterly
yearly
ParticularsJun '22Sep '22Dec '22Mar '23Jun '23
Revenue86.0690.5282.0180.4664.95
Expenses69.4271.8471.4969.4057.69
EBITDA17.0318.8910.7312.537.84
EBIT16.8518.7010.5411.34-39.12
Profit Before Tax16.6518.6810.5311.07-39.41
Net Profit14.1515.498.238.10-41.34
Financial Ratios
Earning Per Share (Diluted)14.1515.498.037.86-39.93
Dividends Per Share0.000.000.000.000.00
Operating Profit Margin20.57%21.87%12.39%17.85%-58.88%
Net Profit Margin17.09%17.93%9.51%13.66%5.15%
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ